Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevance Health, Inc. Common Stock (NY:ELV)

403.29 +13.29 (+3.41%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance
Elevance Health surpasses Q2 profit and revenue estimates, reporting $43.2 billion in revenue and $2.3 billion in profit. Despite a 5% decline in medical membership due to Medicaid attrition, premium... 
Via Benzinga
Elevance Health Reports Second Quarter 2024 Results
From Elevance Health, Inc.
Via Business Wire
Evaluating Elevance Health: Insights From 15 Financial Analysts
Via Benzinga
3 Stocks to Buy From the ‘Ultimate’ Buy-and-Hold Portfolio
Finding stocks to buy and hold for the long haul is sometimes as easy as grabbing a few suggestions from a seasoned investment pro. 
Via InvestorPlace
Elevance Health Releases Impact Report
From Elevance Health, Inc.
Via Business Wire
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,100 Today
Via Benzinga
16 Analysts Have This To Say About Elevance Health
Via Benzinga
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 10 Years
Via Benzinga
Tame Volatility With These 3 Low Beta Stocks
Beta measures a stock's volatility in comparison to the overall market. Three low-beta stocks could all be considered for those looking for a more conservative approach. 
Via Talk Markets
Elevance Stock Elevated On Excellent Marketing Execution
Elevance stock boasts a 92 EPS Rating out of 99. It has an 86 Composite Rating and a B+ Accumulation/Distribution Rating. 
Via Investor's Business Daily
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024
From Elevance Health, Inc.
Via Business Wire
Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued
Morgan Stanley initiates coverage on Elevance Health with an Overweight rating and a $643 price target. Elevance Health's diversified offerings and growth potential in Medicare Advantage, PBM,... 
Via Benzinga
The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits
Explore three top growth-ready healthcare stocks to buy amid rising demand for healthcare services globally. 
Via InvestorPlace
How Is The Market Feeling About Elevance Health?
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,100 Today
Via Benzinga
Beyond The Numbers: 12 Analysts Discuss Elevance Health Stock
Via Benzinga
3 Healthcare Stocks to Buy as Medicare Goes Private
The privatization of Medicare makes these three healthcare stocks to buy worthy of consideration for your portfolio. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Value Stocks With Low Debt And Strong Growth
One of the problems we are facing as a value investor is an extremely high stock market and an aberrantly long-running bull market. It’s one of the longest in recorded history. 
Via Talk Markets
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index highlights five stocks that are seeing increased interest from readers during the week. 
Via Benzinga
Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday
Via Benzinga
Here's How Much $100 Invested In Elevance Health 10 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 5 Years
Via Benzinga
Elevance Health Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference
From Elevance Health, Inc.
Via Business Wire
Why UnitedHealth Stock Is Sliding Wednesday
UnitedHealth Group Inc. (NYSE: UNH) saw its shares decline significantly following remarks made by CEO Andrew Witty at the Bernstein 40th Annual Strategic Decisions Conference. 
Via Benzinga
UnitedHealth Costs Dow Jones 147 Points On Medicaid 'Disturbance'
UnitedHealth CEO Andrew Witty warned of low Medicaid reimbursements. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Cigna Stock Hovers Near All-time High Amid Healthy Profit Growth
Cigna stock is building a flat base with a 365.71 buy point., which is also its all-time high, set on March 28. 
Via Investor's Business Daily
Elevance Health Announces Appearance at Bernstein’s 40th Annual Strategic Decisions Conference
From Elevance Health, Inc.
Via Business Wire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The weekly Stock Whisper Index highlights five stocks seeing increased interest from Benzinga readers. 
Via Benzinga
AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
From AREX Capital Management, LP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.